Lokelma 10 g powder for oral suspension
Sponsors
Academisch Ziekenhuis Leiden, Hospital Clinico Universitario De Valencia, Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA
Conditions
Chronic heart failure (NYHA I-III) and non-dialysis CKDHyperkalemia in patients with chronic kidney diseasePatients with chronic kidney disease stage 3b to 4
Phase 3
Sodium zirconium cyclosilicate to allow liberal fruit and vegetable intake for patients with CKD stage 3b and 4 (LIBERAL study)
CompletedCTIS2023-507823-52-00
Start: 2024-05-27End: 2025-03-12Target: 16Updated: 2024-11-28
A Randomized Clinical Trial, Multicentre, Open-label, Parallel-group, to define the best Strategy for the management of hEart failure aNd chronic kidney disease among elderly patients with or at high risk of hyperKalemia in spAin by optimizing the use of RAASi with SZC: SENEKA Study
RecruitingCTIS2024-513971-42-00
Start: 2024-10-01Target: 94Updated: 2025-08-27
Phase III, multicenter, open-label, randomized clinical trial to evaluate efficacy of Sodium Zirconium Cyclosilicate (Lokelma) compared to standard of care to manage hyperkalemia in patients with chronic kidney disease (CKD)
RecruitingCTIS2024-517631-43-00
Start: 2022-12-12Target: 78Updated: 2024-09-16